Top Companies in Automated Breast Ultrasound System (ABUS) Market Expert Analysis
Automated Breast Ultrasound System (ABUS) Market to Reach Valuation of USD 1807.3 Million by 2028 - Rising breast cancer incidences and prevalence is Driving the Market.
Coralia.Joe
Market Overview:
According to vantage market research, the Global Automated Breast Ultrasound System (ABUS) market is valued at USD 705.5 Million in 2021 and is projected to attain a value of USD 1807.3 Million by 2028 at a CAGR of 15.9% during the forecast period, 2022–2028. The most common form of cancer found in women is breast cancer. It has spread worldwide and is a serious health concern as it is the major type of cancer found in the female population. In order to reduce the morbidity & mortality rates and increase survival chances, healthcare providers focus on its early detection. Well-established technologies such as Mammography and ultrasound are used for screening and early detection of breast cancer. Mammography technology has presented promising results in the detection of tumors in women with the help of ultrasound techniques.
Automated breast ultrasound (ABUS) is a recent technology developed in the field of ultrasound imaging that is developed to obtain an operator-independent system. ABUS is a reproducible system and obtains high resolution through three-dimensional imaging. This system contributes to handling comfort, accuracy, and time-efficiency in various research activities. The ABUS provides high features in cancer detection by providing detection rate, image quality, higher sensitivity, and diagnostic accuracy rates. Recent advancements in ABUS systems help higher-frequency transducers to facilitate the reproduction of superior quality images within short time period. All these parameters are responsible for augmenting the growth of the Automated Breast Ultrasound System (ABUS) Market in upcoming years.
Increasing breast cancer prevalence & incidences, growing awareness of patients toward the connection of breast density, and rising radiology demand for treating breast cancer are fuelling the growth of Automated Breast Ultrasound System (ABUS) Market for the past few years. In addition, increasing government support towards spreading the breast cancer awareness should further enhance the industry demand. Technological improvements for using upgraded imaging techniques along with heavy investments provide effective growth in the market. Benefits provided by the automated breast ultrasound system include 3D imaging, coronal view, high-quality imaging, and rapid results with the assurance of improved diagnostic. These benefits are augmenting the growth of the Automated Breast Ultrasound System (ABUS) Market in coming years. Furthermore, rising cases of breast cancer every year, especially in the female population, and rising healthcare expenditures will provide various growth opportunities for Automated Breast Ultrasound System (ABUS) Market in the near future. The major reasons in the growth of breast cancer in women are reduced childbearing, age-related risks, obesity, and hormonal imbalance.
Following are the top 10 companies in the Automated Breast Ultrasound System (ABUS) Market:
|
Company Name |
Revenue in USD |
|
$22 Million |
|
$18 Billion |
|
$65 Billion |
|
$23 Billion |
|
<$5 Million |
|
<$5 Million |
|
<$5 Million |
|
Siemens AG |
$17 Billion |
|
SonoCine Inc. |
$5 Million |
|
SuperSonic Imagine |
$32 Million |
Canon Medical Systems Corporation is a medical equipment company based in Otawara, Tochigi, Japan. Formerly known as Toshiba Medical, a subsidiary of Toshiba, the company was the first in Japan to begin research on X-ray tubes in 1914, and has continued to be a national leader in diagnostic imaging equipment. Canon Medical Systems is the Official Medical Systems Partner of Manchester United FC as per a multi-million 5-year contract. The company offers a full range of diagnostic medical imaging solutions including CT, MR, X-Ray, Ultrasound, and Healthcare Informatics across the globe. The company also provides integrated diagnostic solutions through long-term, customer-focused partnerships to improve the quality of life for all people.
GE Healthcare is an American multinational company founded in 1994. The company provides services to industries and healthcare sector. These include Imaging, Ultrasound technology, Healthcare IT, Contrast Media, Anesthesia Delivery Drugs, Diagnostic ECG, Maternal Infant Care solutions, Patient Monitors, and various others. The company supports digital infrastructure, medical technologies, data analytics, and decision support tools that help healthcare professionals diagnose, treat, and monitor their patients. The company also provides services, consumables, education, accessories, consulting, and training. The company offers various operating segments such as imaging, ultrasound, life science care, and enterprise software and solutions. The company is headquartered in Chicago, Illinois. In 2020, the company had 54,000 employees working across the globe. The company’s parent organization is General Electric.
Hitachi, Ltd. is a Japanese multinational conglomerate corporation headquartered in Chiyoda, Tokyo, Japan. It is the parent company of the Hitachi Group and had formed part of the Nissan zaibatsu and later DKB Group and Fuyo Group of companies before DKB and Fuji Bank merged into the Mizuho Financial Group. Hitachi conducts business ranging from IT, including AI, the Internet of Things, and big data, to infrastructure. Hitachi is listed on the Tokyo Stock Exchange and Nagoya Stock Exchange and its Tokyo listing is a constituent of the Nikkei 225 and TOPIX Core30 indices.
Koninklijke Philips NV is a Dutch multinational conglomerate corporation that was founded in Eindhoven in 1891. Since 1997, it has been mostly headquartered in Amsterdam, though the Benelux headquarters is still in Eindhoven. In 2020, the company generated revenue of USD 1,953.5 Million and has 81,592 employees working across the globe. The company is listed as IBM (NYSE) in the New York Stock exchange. The company has various subsidiaries such as Respironics, Inc., Saeco, Magnavox, Philips Records, and various others.
MetriTrack, Inc. is a privately owned medical device technology company focused on advancing the current state of breast cancer care. The company provides automated solutions for breast ultrasound. The innovations are designed to find more breast cancers, faster and at a lower cost than possible today. The company is privileged to partner with radiology and business experts who comprise our advisory board. Each advisor shares commitment to helping more women survive breast cancer. The council will continue to contribute to the company's R&D and Commercialization plans, enabling us to bring our novel technology system to providers and patients worldwide.
Nova Medical is a world-renowned manufacturer of a wide variety of state-of-the-art medium and high-field RF products. It is located in approximately 10,000 square feet of manufacturing space that includes a well-equipped RF laboratory, Autocad/Solidworks-based design workstations, and 3D printing capabilities.
QView Medical, Inc. is a Silicon Valley-based private company. The QView team has been the leader in CAD and ABUS development. For over 20 years, members of the team have been involved in obtaining four PMA approvals: R2 mammography CAD, R2 lung CT CAD, U-Systems somo.v ABUS and QView QVCAD.
Siemens AG was established in 1847. Headquartered in Germany, the company is engaged in electrification, automation, and digitalization with a strong presence in over 200 countries. The company operates through the following reportable segments power & gas, energy management, building technologies, mobility, digital factory, and process industries. The mobility division combines all company's businesses in the area of passenger and freight transportation, including rail vehicles, rail automation systems, rail electrification systems, road traffic technology, digital solutions, and electromobility.
SonoCine Inc. provides a consistent, repeatable scan of the whole breast including the axilla. Clinical studies show that adding SonoCiné to a yearly mammogram can improve cancer detection results. The company follows three steps including patient preparation, patient exam, and interpreting the results. The company has developed a proprietary camisole that fits like a sports bra, which holds the breasts in place and provides a sense of feeling of modesty.
Founded in 2005 and based in Aix-en-Provence, SuperSonic Imagine is a company specializing in medical imaging. The company designs develop and market a new generation ultrasound system, Aixplorer®, with an UltraFastTM platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible, and non-invasive manner. This innovation, ShearWaveTMElastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver, and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer® on the main markets.
Get Free Sample Here: https://www.vantagemarketresearch.com/automated-breast-ultrasound-system-abus-market-1313/request-sample
For More Information about each of these companies. Vantage Market Research Report comes up with a detailed analysis of each major player in the industry. The Study provides Global market size & share, Emerging trends, In-depth analysis of key players, Development opportunities, Sales, Revenue Forecast.
